Nathan Hasson
YOU?
Author Swipe
View article: P-648. Shorter <i>vs</i> Standard-Duration Antibiotic Therapy for Nocardiosis: A Multicenter Retrospective Cohort Study
P-648. Shorter <i>vs</i> Standard-Duration Antibiotic Therapy for Nocardiosis: A Multicenter Retrospective Cohort Study Open
Background The recommendation to treat nocardiosis for long durations (usually 6-12 months) relies on small case series published decades ago. We implemented real-world data to assess the association between treatment duration and outcomes…
View article: Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study Open
Purpose The prolonged treatment recommended for nocardiosis does not rely on strong evidence. Consequently, some clinicians opt shorter therapy in certain circumstances. We assessed the effectiveness of shorter therapy. Methods A multi-cen…
View article: Anti-Sp4 and anti-CCAR1 autoantibodies in UK <i>vs</i> US patients with adult and juvenile-onset anti-TIF1γ-positive myositis
Anti-Sp4 and anti-CCAR1 autoantibodies in UK <i>vs</i> US patients with adult and juvenile-onset anti-TIF1γ-positive myositis Open
Objectives Anti-transcriptional intermediary factor 1γ (TIF1γ) autoantibodies are associated with malignancy in adult-onset idiopathic inflammatory myopathy (IIM) and this risk is attenuated if patients are also positive for anti-specifici…
View article: TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients Open
International audience
View article: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part three
Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part three Open